Published in J Antimicrob Chemother on May 01, 1989
Once-daily aminoglycoside therapy. Antimicrob Agents Chemother (1991) 2.31
Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ (1996) 2.29
Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother (1999) 1.90
Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model. Antimicrob Agents Chemother (1992) 1.42
Once-daily aminoglycoside therapy: potential ototoxicity. Antimicrob Agents Chemother (1996) 1.39
Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrob Agents Chemother (1992) 1.24
Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. Antimicrob Agents Chemother (1995) 1.00
In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model. Antimicrob Agents Chemother (1996) 0.82
Aminoglycoside therapy: current and prospective uses. Tex Heart Inst J (1990) 0.75
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Laparoscopic repair of perforated peptic ulcer. Br J Surg (1992) 3.35
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94
Laparoscopic versus open appendicectomy: prospective randomised trial. Lancet (1993) 2.83
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73
Randomized trial of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Br J Surg (1998) 2.73
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Obturator hernia revisited: a review of 12 cases in 7 years. J R Coll Surg Edinb (1997) 2.35
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res (1999) 2.19
beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer (2001) 2.17
Sutureless laparoscopic treatment of perforated duodenal ulcer. Br J Surg (1993) 2.17
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
Prospective comparison of laparoscopic and conventional anterior resection. Br J Surg (1993) 2.15
Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10
The clinical significance of routine histopathologic study of the resected appendix and safety of appendiceal inversion. Surg Gynecol Obstet (1986) 2.02
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg (1999) 1.98
Conventional versus laparoscopic surgery for acute appendicitis. Br J Surg (1993) 1.93
Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93
Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92
A comparison of double-strength beclomethasone dipropionate (84 microg) MDI with beclomethasone dipropionate (42 microg) MDI in the treatment of asthma. Chest (1997) 1.92
The bacteriology and septic complication of patients with appendicitis. Ann Surg (1984) 1.89
Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86
Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83
Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem (1998) 1.82
Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol (2000) 1.79
Spontaneous rupture of hepatocellular carcinoma: a systematic review. Arch Surg (2006) 1.77
Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res (1999) 1.77
Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Am J Gastroenterol (2000) 1.73
High incidence of single nucleotide substitutions in the mitochondrial genome is associated with poor semen parameters in men. Int J Androl (2001) 1.68
Spontaneous rupture of hepatocellular carcinoma. Br J Surg (1996) 1.68
Predicting mortality and morbidity of patients operated on for perforated peptic ulcers. Arch Surg (2001) 1.65
Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg (1990) 1.63
Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg (1998) 1.63
Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol (2000) 1.62
High prevalence of Helicobacter pylori infection in duodenal ulcer perforations not caused by non-steroidal anti-inflammatory drugs. Br J Surg (1996) 1.62
Treatment of hemorrhoids with circular stapler, a new alternative to conventional methods: a prospective study of 140 patients. J Am Coll Surg (2001) 1.60
Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg (2007) 1.56
Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg (1998) 1.54
Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: A prospective randomized trial. Ann Surg (2000) 1.53
Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg (2001) 1.52
Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys (1995) 1.50
Selective hepatic vascular exclusion versus Pringle manoeuvre in liver resection for tumours encroaching on major hepatic veins. Br J Surg (2012) 1.47
Selective internal radiation therapy with intra-arterial iodine-131-Lipiodol in inoperable hepatocellular carcinoma. J Nucl Med (1994) 1.45
Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med (1996) 1.44
Limitations and dangers of gastrografin swallow after esophageal and upper gastric operations. Am J Surg (1988) 1.44
Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg (1998) 1.42
Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth (2003) 1.42
Resection of phaeochromocytoma extending into the right atrium in a patient with multiple endocrine neoplasia type 2A. Hong Kong Med J (2005) 1.42
Quality of life after surgical resection compared with radiofrequency ablation for small hepatocellular carcinomas. Br J Surg (2014) 1.41
Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol (2001) 1.41
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40
High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene (1999) 1.40
Food bolus intestinal obstruction in a Chinese population. Aust N Z J Surg (1997) 1.40
Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39
Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39
Pancreatic pleural effusion: an indication for emergency distal pancreatectomy and Roux-en-Y pancreatico-jejunostomy. J Pediatr Surg (1994) 1.38
Eradication of Helicobacter pylori prevents recurrence of ulcer after simple closure of duodenal ulcer perforation: randomized controlled trial. Ann Surg (2000) 1.37
The continuing challenge of hepatic cancer in Asia. Surgeon (2005) 1.36
Early decision for conversion of laparoscopic to open cholecystectomy for treatment of acute cholecystitis. Am J Surg (1997) 1.36
Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg (1994) 1.34
Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer (1995) 1.33
Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology (1987) 1.33
Gallbladder cancer--a comprehensive review. Surgeon (2008) 1.33
Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology (1990) 1.31
Spontaneous rupture of hepatocellular carcinoma and vascular injury. Arch Surg (2001) 1.30
Laparoscopic-assisted resection of colorectal carcinoma: five-year audit. Dis Colon Rectum (1999) 1.29
Factors affecting conversion of laparoscopic cholecystectomy to open surgery. Arch Surg (1996) 1.28
Pyogenic liver abscess. An audit of experience over the past decade. Arch Surg (1996) 1.27
Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res (1999) 1.27
Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo. Antimicrob Agents Chemother (1987) 1.26
Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut (1989) 1.26
Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer (1992) 1.25
Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer (1998) 1.24
Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol (2000) 1.24
Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer (1994) 1.23
Biliary complications during liver resection. World J Surg (2001) 1.23
Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg (1999) 1.22
Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res (2000) 1.22
Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization. Br J Surg (1998) 1.22
Acute torsion of the gall bladder in the aged: a re-emphasis on clinical diagnosis. Aust N Z J Surg (1982) 1.21
Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg (1998) 1.21
Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci (1991) 1.20
Optimal position of working ports in laparoscopic surgery: an in vitro study. Surg Laparosc Endosc (1996) 1.20
Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann Surg (1998) 1.20
Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc (1999) 1.19
Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am J Pathol (2001) 1.19